Papilloma virus capsomere vaccine formulations and methods of use

Details for Australian Patent Application No. 2003200653 (hide)

Owner Loyola University of Chicago

Inventors Muller, Martin; Gissman, Lutz

Agent Shelston IP

Pub. Number AU-B-2003200653

Parent 96846

Filing date 25 February 2003

Wipo publication date 1 May 2003

Acceptance publication date 18 January 2007

International Classifications

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

Event Publications

13 March 2003 Complete Application Filed

1 May 2003 Application Open to Public Inspection

  Published as AU-B-2003200653

18 January 2007 Application Accepted

  Published as AU-B-2003200653

17 May 2007 Standard Patent Sealed

3 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003200654-International automatic line height, font size and font measurement system and method

2003200652-Matrix metalloproteinase and tumor necrosis factor inhibitors